Medical Device News Magazine

HORIBA Introduces Network Option for Digital Morphology Training Tool for Multiple User Access in Multiple Locations

50-user access ideal for large hospital trusts and University/Medical School remote haematology learning activities

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

HORIBA UK Limited will introduce a new network license option for its QSP 2.0 (Quality Slide Program) affordable digital tool for skill evaluation and training in morphology at IBMS Congress 2022.

HORIBA advises this now enables up to 50 users across various locations, even in different countries, to directly access this valuable digital morphology resource as it works on VPN and local networks. The new QSP 2.0 Network Licence is ideal for large hospital Trusts with multiple sites and users, or Universities/Medical Schools for remote teaching and learning activities.

QSP 2.0 is a unique cross-platform hematology training program offering access to detailed blood morphology knowledge covering a huge diversity of pathologies seen globally. As an intuitive educational blood cell identification tool using high-definition digital cell morphology imaging, the QSP 2.0 software enables laboratory staff to clearly examine and report on digital blood films that have been pre-selected and reviewed by experts. Six digital cell morphology virtual slides are available for evaluation monthly.

This regular review process via QSP 2.0 not only supports staff and student learning and continued development, it also helps to standardize an area of the laboratory that can be subjective. Laboratory management can assess the competence of their staff in correctly classifying individual white blood cell (WBC) populations and other identifiable elements in accordance with the quality control requirements of ISO15189.

As well as the new Network Licence option, the QSP 2.0 online morphology training package is also available in Single Licence and Site Licence formats. A single license is intended for use on an individual computer, such as within a laboratory, whereas a site license is available for up to 10 concurrent computers where QSP 2.0 is installed and managed, for example, those around a single hospital site. The new networked version of QSP 2.0 offers a shared database, integrated reports, and automated installation of the software on up to 50 licensed computers in the network. This boosts its accessibility.

Also included in the QSP 2.0 training package are educational newsletters which help users to update themselves quickly with important and unique real-life hematology cases from around the world. They share detailed cytology case studies, scientific features, quick tips and a review of the latest six training slides. A library of all current and previous issues is available for free access on HORIBA Medical’s website at: https://www.horiba.com/en_en/medical/qsp-newsletter/

HORIBA’s QSP 2.0 digital blood cell morphology training tool will be available for live demonstrations at IBMS Congress 2022 on HORIBA’s Stand 615 at Birmingham’s ICC from 14-17 March. Visitors will also have the opportunity to participate in a morphology quiz and win a limited QSP 2.0 license.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”